EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD47 Expression Analysis Between Microsatellite Stable and Instable Subtypes in Colorectal Cancer

Ömer Eronat, Latif Yılmaz, Serdar Öztuzcu

The European Research Journal · 19.11.2026 · 1-10

DOI: 10.18621/eurj.1418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The European Research Journal, online erschienen am 19.11.2026. Verfasst von Ömer Eronat und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Colorectal cancer (CRC) is a leading cause of cancer-related mortality. Although the immune checkpoint protein CD47 is frequently overexpressed in CRC, reported expression rates vary widely across studies. This study aimed to evaluate immunohistochemical CD47 expression in CRCs and assess its association with clinicopathologic prognostic parameters and mismatch repair (MMR) status.

Methods

Tissue specimens and clinical records of 100 patients with resected CRC—comprising 52 with proficient MMR (pMMR) and 48 with deficient MMR (dMMR)—were retrospectively evaluated. Immunohistochemical staining for CD47 was performed, and expression levels were analyzed in relation to clinicopathologic features and MMR status.

Results

Positive CD47 expression was detected in 11 of 100 cases (11.0%), including 10 with weak staining and 1 with moderate staining. CD47 positivity was significantly associated with poor histological differentiation (P = .01). No significant associations were observed between CD47 expression and sex (P = .75), distant metastasis (P = .65), lymph node involvement (P > .99), pathological stage (P = .09), or MMR status (6 of 48 [12.5%] in dMMR vs 5 of 52 [9.6%] in pMMR; P = .65). Age (P = .02) and tumor size (P = .001) differed significantly between the dMMR and pMMR groups.

Conclusions

Although CD47 expression was associated with poor histological differentiation, no associations were found with other prognostic parameters or MMR status, largely reflecting the low overall positivity rate. While CD47 continues to rise as a potential and promising target in CRC immunotherapy, our study urges the need of a standardized working protocol to minimize the currently present different expression results.

Zitieren

APA

Eronat, Ö., Yılmaz, L., & Öztuzcu, S. (2026). CD47 Expression Analysis Between Microsatellite Stable and Instable Subtypes in Colorectal Cancer. The European Research Journal, 1-10. https://doi.org/10.18621/eurj.1418

Vancouver

Eronat Ö, Yılmaz L, Öztuzcu S. CD47 Expression Analysis Between Microsatellite Stable and Instable Subtypes in Colorectal Cancer. The European Research Journal. 2026:1-10. doi:10.18621/eurj.1418

BibTeX
@article{Eronat2026,
  author = {Eronat, Ömer and Yılmaz, Latif and Öztuzcu, Serdar},
  title = {CD47 Expression Analysis Between Microsatellite Stable and Instable Subtypes in Colorectal Cancer},
  journal = {The European Research Journal},
  year = {2026},
  pages = {1--10},
  doi = {10.18621/eurj.1418}
}
Kostenlos starten →